PL2699545T3 - Nowe pochodne aminopirolinowe, ich zastosowanie w zapobieganiu i/lub leczeniu zespołu metabolicznego - Google Patents
Nowe pochodne aminopirolinowe, ich zastosowanie w zapobieganiu i/lub leczeniu zespołu metabolicznegoInfo
- Publication number
- PL2699545T3 PL2699545T3 PL12722423T PL12722423T PL2699545T3 PL 2699545 T3 PL2699545 T3 PL 2699545T3 PL 12722423 T PL12722423 T PL 12722423T PL 12722423 T PL12722423 T PL 12722423T PL 2699545 T3 PL2699545 T3 PL 2699545T3
- Authority
- PL
- Poland
- Prior art keywords
- prevention
- treatment
- metabolic syndrome
- novel amino
- pyrroline derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1153375A FR2974364B1 (fr) | 2011-04-19 | 2011-04-19 | Nouveaux derives amino-pyrroliniques, leur utilisation dans la prevention et/ou le traitement du syndrome metabolique |
| FR1251302 | 2012-02-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2699545T3 true PL2699545T3 (pl) | 2017-01-31 |
Family
ID=46146922
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12722423T PL2699545T3 (pl) | 2011-04-19 | 2012-04-17 | Nowe pochodne aminopirolinowe, ich zastosowanie w zapobieganiu i/lub leczeniu zespołu metabolicznego |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9303019B2 (pl) |
| EP (1) | EP2699545B1 (pl) |
| JP (1) | JP5986625B2 (pl) |
| CN (1) | CN103619814B (pl) |
| CA (1) | CA2833339C (pl) |
| CY (1) | CY1118117T1 (pl) |
| DK (1) | DK2699545T3 (pl) |
| ES (1) | ES2588059T3 (pl) |
| HR (1) | HRP20161024T1 (pl) |
| HU (1) | HUE030432T2 (pl) |
| LT (1) | LT2699545T (pl) |
| PL (1) | PL2699545T3 (pl) |
| PT (1) | PT2699545T (pl) |
| RS (1) | RS55061B1 (pl) |
| SI (1) | SI2699545T1 (pl) |
| SM (1) | SMT201600284B (pl) |
| WO (1) | WO2012143660A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104995171B (zh) * | 2012-12-19 | 2018-02-06 | 拜耳作物科学股份公司 | 作为杀真菌剂的二氟甲基‑烟碱‑茚满基甲酰胺 |
| WO2023084054A1 (en) | 2021-11-12 | 2023-05-19 | 3Z Ehf | Treatment of adhd using selective binders of the 11-imidazoline receptor |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1670859A1 (de) * | 1967-04-24 | 1971-03-11 | Bayer Ag | Verfahren zur Herstellung von 2-Phenyl-imino-1-azacycloalkanen |
| US3679692A (en) * | 1969-10-01 | 1972-07-25 | Mead Johnson & Co | Iminomethylindolines |
| US4533739A (en) | 1982-10-12 | 1985-08-06 | G. D. Searle & Co. | 2-[(Aminophenyl and amidophenyl)amino]-1-azacycloalkanes having antidiarrheal activity |
| US4579951A (en) * | 1984-03-19 | 1986-04-01 | G. D. Searle & Co. | Substituted (azacycloalk-2-yl)iminophenols and esters thereof |
| AU2010303545B2 (en) * | 2009-10-06 | 2016-05-12 | Allergan, Inc. | 2H-pyrrol-5-amine derivatives as alpha adrenergic receptor modulators |
| KR20120098720A (ko) * | 2009-10-21 | 2012-09-05 | 알러간, 인코포레이티드 | 알파 아드레날린 수용체 변형제 |
-
2012
- 2012-04-17 PT PT127224236T patent/PT2699545T/pt unknown
- 2012-04-17 DK DK12722423.6T patent/DK2699545T3/en active
- 2012-04-17 SI SI201230681A patent/SI2699545T1/sl unknown
- 2012-04-17 CN CN201280019520.6A patent/CN103619814B/zh not_active Expired - Fee Related
- 2012-04-17 PL PL12722423T patent/PL2699545T3/pl unknown
- 2012-04-17 EP EP12722423.6A patent/EP2699545B1/fr active Active
- 2012-04-17 US US14/112,631 patent/US9303019B2/en not_active Expired - Fee Related
- 2012-04-17 WO PCT/FR2012/050835 patent/WO2012143660A1/fr not_active Ceased
- 2012-04-17 HR HRP20161024TT patent/HRP20161024T1/hr unknown
- 2012-04-17 CA CA2833339A patent/CA2833339C/fr not_active Expired - Fee Related
- 2012-04-17 HU HUE12722423A patent/HUE030432T2/en unknown
- 2012-04-17 RS RS20160689A patent/RS55061B1/sr unknown
- 2012-04-17 LT LTEP12722423.6T patent/LT2699545T/lt unknown
- 2012-04-17 JP JP2014505700A patent/JP5986625B2/ja not_active Expired - Fee Related
- 2012-04-17 ES ES12722423.6T patent/ES2588059T3/es active Active
-
2016
- 2016-08-22 CY CY20161100829T patent/CY1118117T1/el unknown
- 2016-08-23 SM SM201600284T patent/SMT201600284B/it unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP5986625B2 (ja) | 2016-09-06 |
| PT2699545T (pt) | 2016-08-30 |
| HRP20161024T1 (hr) | 2016-11-04 |
| CA2833339A1 (fr) | 2012-10-26 |
| LT2699545T (lt) | 2016-09-26 |
| HUE030432T2 (en) | 2017-05-29 |
| RS55061B1 (sr) | 2016-12-30 |
| JP2014514316A (ja) | 2014-06-19 |
| WO2012143660A1 (fr) | 2012-10-26 |
| US9303019B2 (en) | 2016-04-05 |
| SI2699545T1 (sl) | 2016-12-30 |
| CN103619814B (zh) | 2016-01-20 |
| SMT201600284B (it) | 2016-11-10 |
| US20140045910A1 (en) | 2014-02-13 |
| EP2699545B1 (fr) | 2016-05-25 |
| CY1118117T1 (el) | 2017-06-28 |
| EP2699545A1 (fr) | 2014-02-26 |
| ES2588059T3 (es) | 2016-10-28 |
| CA2833339C (fr) | 2020-09-15 |
| DK2699545T3 (en) | 2016-08-29 |
| CN103619814A (zh) | 2014-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2478595B (en) | Phytocannabinoids in the treatment of glioma | |
| IL231536A (en) | Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases | |
| IL235923B (en) | Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical preparations thereof | |
| IL231386A (en) | Pyrazolequinoline derivatives, their preparation and medical use | |
| LT2739615T (lt) | Fenil-3-aza-biciklo[3.1.0]heks-3-il-metanonai ir jų panaudojimas kaip vaisto | |
| IL238027A0 (en) | 2-phenyl-5-heterocyclyl-tetrahydro-h2-pyran-3-amine compounds for use in the treatment of diabetes and related disorders | |
| GB2497453B (en) | Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV | |
| PL2854910T3 (pl) | Poziomy ceramidu w leczeniu i zapobieganiu infekcjom | |
| ZA201402452B (en) | Novel pyrimethanil formulations and uses thereof in the treatment of crops | |
| ZA201403592B (en) | Composition for use in the promotion of magnesium absorption and/or magnesium retention | |
| ZA201307058B (en) | Use of polyaminoisoprenyl derrivatives in antobiotic or antisertic treatment | |
| GB201208850D0 (en) | Tri-subsituted glycerol compounds for use in the treatment of clinically isolated syndrome and/or multiple sclerosis | |
| ZA201503266B (en) | Pyidone derivatives and uses thereof in the treatment of tuberculosis | |
| PT2699545T (pt) | Novos derivados amino-pirrolínicos, sua utilização na prevenção e/ou tratamento do síndrome metabólico | |
| ZA201408053B (en) | Compositions and methods for the treatment of metabolic syndrome | |
| PL2702033T3 (pl) | Zastosowanie soli 3-karboksy-N-etylo-N,N-dimetylopropano-1-amoniowych do leczenia choroby układu krążenia | |
| PL2771016T3 (pl) | Prymycyna i jej składniki do zastosowania w leczeniu lub zapobieganiu infekcjom powodowanym przez określone patogeny | |
| ZA201600894B (en) | Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the prevention and treatment of diabetes | |
| ZA201307614B (en) | Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease | |
| PT2389936E (pt) | Aminaftona para utilização no tratamento e/ou prevenção de enxaqueca | |
| HK1193342A (en) | Pharmaceutical combination for use in the treatment of diabetes type 2 | |
| AU2012905072A0 (en) | The use of bucillamine in the treatment of gout |